Artios Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Artios Pharma's estimated annual revenue is currently $20.5M per year.
- Artios Pharma's estimated revenue per employee is $155,000
- Artios Pharma's total funding is $298.3M.
Employee Data
- Artios Pharma has 132 Employees.
- Artios Pharma grew their employee count by 13% last year.
Artios Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO and interim CFO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Head Invivo Pharmacology | Reveal Email/Phone |
4 | VP Biology | Reveal Email/Phone |
5 | VP Clinical Development | Reveal Email/Phone |
6 | VP Clinical Development | Reveal Email/Phone |
7 | VP Chemistry | Reveal Email/Phone |
8 | VP Scientific Strategy | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Chief Business Officer | Reveal Email/Phone |
Artios Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Artios Pharma?
Artios is a leading independent DNA Damage Response (DDR) company focussed on developing first-in-class treatments for cancer. Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery. Artios is building a pipeline of next-generation DDR programmes, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK (CRUK), and with leading DNA repair researchers worldwide. The Company?s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK.
keywords:N/A
$298.3M
Total Funding
132
Number of Employees
$20.5M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Artios Pharma News
Artios is a clinical-stage biotech company pioneering the development of novel small molecule therapeutics that target the DDR process to treat...
Artios Pharma Limited: Also based in the United Kingdom, Artios Pharma announced its ataxia telangiectasia and Rad3-related Inhibitor,...
The research is funded by Wellbeing of Women in partnership with Artios Pharma Limited (Artios). Dr Gillian Langford, vice president of clinical...
Arix Bioscience PLC (ARIX) Artios Doses First Patient in Phase 1/2a Study of Pol? Inhibitor ART4215 28-Sep-2021 / 08:15 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. -------------------------- ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $22.4M | 132 | 14% | $78.7M |
#2 | $42.6M | 132 | 2% | N/A |
#3 | $18.5M | 132 | -21% | $110.8M |
#4 | $32.3M | 132 | 22% | N/A |
#5 | $17.3M | 133 | 15% | $81.1M |